Psoriasis Vulgaris: Clinical Trials

203 trials for Psoriasis Vulgaris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

140 completed, 36 unknown, 9 recruiting, 7 terminated. 51 Phase 2, 39 Phase 1, 34 Phase 4, 33 Not applicable, 19 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 251Completed 38, Unknown 9, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Terminated 1
Phase 139Completed 31, Unknown 4, Terminated 2, Enrolling by invitation 1, Recruiting 1
Phase 434Completed 18, Unknown 6, Recruiting 4, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Not applicable33Completed 21, Unknown 8, Not yet recruiting 2, Terminated 1, Withdrawn 1
Phase 319Completed 17, Recruiting 1, Unknown 1
Early Phase 12Unknown 1, Withdrawn 1

Follow Psoriasis Vulgaris: new trials by email Literature Review of Psoriasis Vulgaris trials Research Report on Psoriasis Vulgaris

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ceramol PSOR Cream as an Adjuvant Treatment in Patients With Mild-to-Moderate Psoriasis Treated With Narrowband UVB Phototherapy (CERAMOL PSOR CREMA)
Narrowband UVB Phototherapy, Ceramol PSOR Cream, Comparator Emollient Cream - Psoriasis, Psoriasis; Plaque
Not applicableNot yet recruitingUnifarco SpA1282026-10-012026-09-30
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants
HRS-4139 Tablet, HRS-4139 Placebo - Psoriasis Vulgaris
Phase 1RecruitingFujian Shengdi Pharmaceutical Co., Ltd.402026-09-212026-09-25
Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures
Psoriasis Vulgaris
Not yet recruitingAssiut University452026-05-012026-03-27
Topical Diacerein in Psoriasis Vulgaris
Diacerein, Placebo - Psoriasis Vulgaris
Phase 4RecruitingAlaa Ashraf Muhammad Helal602026-04-112026-10-22
Efficacy of Topical Metformin in Psoriasis Vulgaris
Topical metformin 30% cream, Placebo - Psoriasis Vulgaris
Not applicableNot yet recruitingCairo University552026-04-012026-04-13
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
Total coumarin (TC) cream, Vehicle cream - Psoriasis Vulgaris, Topical Administration
Phase 3RecruitingPsoriasis Research Institute of Guangzhou3002026-02-012026-02-23
Oral and Topical Phytocannabinoids for Psoriasis
Oral Cannabis Extract, Topical cannabis cream - Psoriasis Vulgaris
Phase 2Active not recruitingFederal University of Latin American Integration372025-11-012026-09-24
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
vaspin gene polymorphism - Psoriasis Vulgaris
RecruitingAswan University602025-08-102026-01-06
The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions
Ciplukan, Bethametasone valerate 0,1% cream - Psoriasis Vulgaris, Inflammation
Phase 1 / Phase 2Enrolling by invitationUniversitas Padjadjaran402025-02-132025-04-01
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Proactive TDM-based dosing of secukinumab, Proactive TDM-based dosing of ixekizumab, Proactive TDM-based dosing of guselkumab - Psoriasis Vulgaris
Phase 4RecruitingUniversity Hospital, Ghent2102024-12-202026-03-04
Topical Thymoquinone in Psoriasis Vulgaris
Topical thymoquinone Ointment, topical placebo ointment - Psoriasis Vulgaris
Not applicableUnknownAssiut University302024-08-012024-07-19
Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis
SDD formula, Placebo - Psoriasis Vulgaris
Phase 2RecruitingChinese University of Hong Kong582024-06-112026-07-30
Botox Versus Tacrolimus in Psoriasis Vulgaris
Botulinum Toxin-A, Tacrolimus - Psoriasis Vulgaris
Phase 4Not yet recruitingAssiut University602024-06-012024-06-12
PSODEEP2 Pilot Study on Koebner Induction in Psoriasis
Tape-stripping - Psoriasis Vulgaris, Koebner Phenomenon
Not applicableUnknownSkane University Hospital152024-05-072024-05-16
Impact of the Mediterranean Diet on Patients with Psoriasis
High-intensity Mediterranean diet intervention - Psoriasis, Psoriasis Vulgaris
Not applicableCompletedFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal382024-02-152025-03-21
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
si-544, Placebo - Psoriasis Vulgaris, Psoriatic Arthritis
Phase 1CompletedselectION Therapeutics GmbH452024-01-222025-07-03
Correction of Psoriatic T Cell Signatures by Deucravacitinib
deucravacitinib - Psoriasis Vulgaris
Phase 4RecruitingUniversity of California, San Francisco252023-10-012026-06-04
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate - Psoriasis Vulgaris
Phase 4CompletedDermatology Consulting Services, PLLC102023-07-132023-11-18
The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis Study
The Mediterranean style diet, The UK diet, Time-restricted eating - Psoriasis Vulgaris
Not applicableCompletedKing's College London222023-06-082025-05-04
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
Semaglutide - Psoriasis Vulgaris, Diabetes Type 2
Phase 4CompletedUniversity of Banja Luka302023-05-032024-07-01

Showing 20 of 203. Sign in to see all of them.

Narrower conditions

Psoriasis (49)  ·  Arthritis, Psoriatic (9)  ·  Inflammation (6)  ·  Pruritus (5)  ·  Skin Diseases (5)  ·  Dermatitis, Atopic (4)  ·  Metabolic Syndrome (4)  ·  Plaque, Amyloid (3)  ·  Anxiety Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Depression (2)  ·  Dermatitis (2)  ·  Dermatitis, Seborrheic (2)  ·  Eczema (2)  ·  Guttate Psoriasis (2)

Broader conditions

Skin and Connective Tissue Diseases (60)  ·  Skin Diseases (55)  ·  Skin Diseases, Papulosquamous (54)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Arthritis (10)  ·  Joint Diseases (10)  ·  Musculoskeletal Diseases (10)  ·  Pathologic Processes (10)  ·  Bone Diseases (9)  ·  Spinal Diseases (9)  ·  Spondylarthritis (9)  ·  Spondylarthropathies (9)  ·  Spondylitis (9)  ·  Immune System Diseases (7)  ·  Signs and Symptoms (7)

Interventions

calcipotriene (24)  ·  betamethasone-17,21-dipropionate (8)  ·  betamethasone dipropionate, calcipotriol drug combination (6)  ·  brodalumab (6)  ·  secukinumab (6)  ·  Betamethasone (5)  ·  Gels (4)  ·  Ointments (4)  ·  Phototherapy (4)  ·  guselkumab (4)  ·  Abatacept (3)  ·  Acitretin (3)  ·  Botulinum Toxins, Type A (3)  ·  Hydrocortisone (3)  ·  Methotrexate (3)

Sponsors

LEO Pharma (59)  ·  University Hospital, Ghent (9)  ·  Assiut University (8)  ·  University of California, San Francisco (6)  ·  Istanbul Medeniyet University (4)  ·  MC2 Therapeutics (4)  ·  Bristol-Myers Squibb (3)  ·  Pfizer (3)  ·  Aarhus University Hospital (2)  ·  Cairo University (2)  ·  Central South University (2)  ·  Chang Gung Memorial Hospital (2)  ·  Chulalongkorn University (2)  ·  Galderma R&D (2)  ·  Innovaderm Research Inc. (2)

Countries

United States (43)  ·  Germany (31)  ·  France (27)  ·  Canada (18)  ·  United Kingdom (16)  ·  Belgium (14)  ·  China (11)  ·  Egypt (11)  ·  Japan (9)  ·  Netherlands (8)  ·  Denmark (7)  ·  Poland (7)  ·  Spain (6)  ·  Italy (5)  ·  Turkey (Türkiye) (5)

Top investigators

Catherine Queille-Roussel, MD (6)  ·  Jo Lambert, Prof. (6)  ·  Raymond Cho, MD, PhD (3)  ·  Colin Fleming, MD (2)  ·  Jerry Bagel, MD (2)  ·  Jia Zhou (2)  ·  John Koo, MD (2)  ·  Liping Yang, MD (2)  ·  Mark Lebwohl, MD (2)  ·  Patrice Facy, PhD (2)  ·  Robert Bissonnette, MD (2)  ·  Xiang Chen, MD (2)

Results publications

PMID 32785881, PMID 34397196, PMID 37490268, PMID 40274711, PMID 10022440, PMID 12713574, PMID 15099362, PMID 15214905, PMID 15914609, PMID 17135738, PMID 17310004, PMID 17314973, PMID 20060688, PMID 20555351, PMID 21293107, PMID 21797805, PMID 22361809, PMID 23097521, PMID 23302780, PMID 23392136, PMID 23986161, PMID 25708531, PMID 26044167, PMID 26499368, PMID 26659941, PMID 27440994, PMID 27531752, PMID 27639922, PMID 27714595, PMID 27716172, PMID 28058392, PMID 28236223, PMID 28342016, PMID 28431948, PMID 30697518, PMID 30793796, PMID 31700924, PMID 31797464, PMID 31819584, PMID 32351609, PMID 32378724, PMID 32403379, PMID 32965655, PMID 33068776, PMID 33852251, PMID 34339017, PMID 34463640, PMID 34648147, PMID 34656148, PMID 35195533

NIH funding

2019 (3), 2023 (3), 2009 (2), 2016 (2), 2017 (2), 2014 (1), 2018 (1)